E2	Condition:T2 Name:T16
E3	Drug:T3 Name:T17 Dose:E5
E5	Eq-Comparison:T5 Operator:T18 Value:T19 Unit:T1
E6	Condition:T6 Name:T20
E7	Condition:T7 Name:T21
E8	Temporal-Connection:T8 Arg:E7 Arg2:E9
E9	Study:T9
E10	Observation:T10 Name:T22 Eq-Comparison:E11
E11	Eq-Comparison:T11 Operator:T24 Value:T25 Unit:T26 Per:T27
E12	Condition:T12 Name:T28
E13	Condition:T13 Name:T29
E14	Condition:T14
E15	Negation:T15
T2	Condition 340 328	BH4 deficiency
T3	Drug 373 359	KUVAN
T5	Eq-Comparison 401 386	at least 1 dose
T6	Condition 414 399	HPA
T7	Condition 440 424	BH4 deficiency
T8	Temporal-Connection 447 431	during
T9	Study 473 457	observation
T10	Observation 508 490	Phe concentration
T11	Eq-Comparison 524 503	≥ 450 µmol/L
T12	Condition 593 570	Phenylketonuria
T13	Condition 599 575	PKU
T14	Condition 625 599	condition
T15	Negation 738 710	not
T16	Condition-Name 340 328	BH4 deficiency
T17	Drug-Name 373 359	KUVAN
T18	Eq-Operator 393 379	at least
T19	Eq-Value 396 381	1
T20	Condition-Name 414 399	HPA
T21	Condition-Name 440 424	BH4 deficiency
T22	Observation-Name 508 490	Phe concentration
T24	Eq-Operator 510 492	≥
T25	Eq-Value 515 496	450
T26	Eq-Unit 520 501	µmol
T27	Eq-Unit 524 503	L
T28	Condition-Name 593 570	Phenylketonuria
T29	Condition-Name 599 575	PKU
T1	Eq-Unit 401 386	dose
A1	Temporal-Connection-Type-Value E8 during
A2	Eq-Operator-Value T18 GTEQ
A3	Observation-Type-Value T22 lab
A5	Eq-Operator-Value T24 GTEQ
R1	Treatment-For Arg1:E3 Arg2:E6
R2	Caused-By Arg1:E6 Arg2:E7
R3	Abbrev-Of Arg1:E13 Arg2:E12